GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
227 hedge funds and large institutions have $2.79B invested in Global Blood Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 85 increasing their positions, 62 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $3.51B → $2.79B (-$718M)
24% less call options, than puts
Call options by funds: $43.1M | Put options by funds: $57M
Holders
227
Holding in Top 10
6
Calls
$43.1M
Puts
$57M
Top Buyers
| 1 | +$56.8M | |
| 2 | +$34.7M | |
| 3 | +$27.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$23.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$20.7M |
Top Sellers
| 1 | -$97.6M | |
| 2 | -$46.9M | |
| 3 | -$33.1M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$29.5M |
| 5 |
Millennium Management
New York
|
-$23.8M |